No specific medical condition to be investigated. The trial is to look at physical and radiological characteristic of contrast agent and how it improves interpretation of CT scan.
Conditions
Interventions
Trade Name: Gastrografin
Pharmaceutical Form: Oral solution
Sponsors
Heart of England NHS Foundation Trust Radiology Department
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients referred for elective abdominopelvic CT examination over the study period. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: 1. Patients referred for CT of the oesophagus,stomach and pancreas (national guidelines suggest they should have oral water anyway) 2. Trauma patients referred from A/E: We use water anyway as using gastrograffin is more time consuming, hides mucosal detail, poor transit due to ileus, interferes with intervention etc 3. Specialist CT examination like CT Angiography, CT Enterography, CT Cholangiography, CT Colonography and CT Urography as positive contrast interferes with reconstructions. 4. Patients with acute abdomen - mucosal information is paramount - hence water used anyway 5. Children - water is usual preferred agent anyway
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Our aim is to assess the suitability of water as an oral contrast agent for routine or elective abdomino-pelvic examination compared to the more established positive oral contrast , dilute gastrograffin.;Secondary Objective: To assess patient acceptability of the two regimens and to assess cost implications of the two regimens;Primary end point(s): When the study period ends or when the required number of subjects achieved, whichever earlier. | — |
Countries
United Kingdom
Outcome results
None listed